David J. Kroll

5.7k total citations
99 papers, 4.4k citations indexed

About

David J. Kroll is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David J. Kroll has authored 99 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 29 papers in Pharmacology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David J. Kroll's work include Silymarin and Mushroom Poisoning (16 papers), Microbial Natural Products and Biosynthesis (16 papers) and Cancer therapeutics and mechanisms (14 papers). David J. Kroll is often cited by papers focused on Silymarin and Mushroom Poisoning (16 papers), Microbial Natural Products and Biosynthesis (16 papers) and Cancer therapeutics and mechanisms (14 papers). David J. Kroll collaborates with scholars based in United States, Australia and Jordan. David J. Kroll's co-authors include Nicholas H. Oberlies, Mansukh C. Wani, Rajesh Agarwal, Gagan Deep, Tyler N. Graf, Heather Shaw, Yuka Nakanishi, Steven M. Swanson, Dennis R. Petersen and Cedric J. Pearce and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David J. Kroll

94 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Kroll United States	41	2.3k	1.0k	819	557	523	99	4.4k
Santosh K. Katiyar United States	52	3.3k 1.4×	913 0.9×	519 0.6×	561 1.0×	626 1.2×	130	8.7k
Imtiaz A. Siddiqui United States	50	2.6k 1.1×	676 0.6×	414 0.5×	329 0.6×	455 0.9×	88	6.2k
Xi Zheng China	42	2.9k 1.2×	638 0.6×	393 0.5×	490 0.9×	683 1.3×	203	6.5k
Haruyo Ichikawa United States	29	2.6k 1.1×	829 0.8×	292 0.4×	498 0.9×	525 1.0×	36	5.5k
Katrin Sak India	37	2.8k 1.2×	705 0.7×	312 0.4×	397 0.7×	729 1.4×	125	5.9k
Jong Soon Kang South Korea	39	2.2k 1.0×	790 0.8×	309 0.4×	555 1.0×	617 1.2×	214	5.0k
Hardeep Singh Tuli India	43	3.3k 1.4×	1.1k 1.0×	356 0.4×	590 1.1×	897 1.7×	253	7.3k
Mahadev Rao India	40	3.3k 1.4×	541 0.5×	486 0.6×	527 0.9×	896 1.7×	160	7.8k
Mohammad Saleem United States	42	3.4k 1.4×	427 0.4×	485 0.6×	559 1.0×	925 1.8×	145	6.8k
M. Helena Vasconcelos Portugal	40	3.1k 1.3×	1.3k 1.3×	266 0.3×	526 0.9×	751 1.4×	164	6.1k

Countries citing papers authored by David J. Kroll

Since Specialization

Citations

This map shows the geographic impact of David J. Kroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Kroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Kroll more than expected).

Fields of papers citing papers by David J. Kroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Kroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Kroll. The network helps show where David J. Kroll may publish in the future.

Co-authorship network of co-authors of David J. Kroll

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Kroll. A scholar is included among the top collaborators of David J. Kroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Kroll. David J. Kroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kroll, David J., et al.. (2025). Flipped townhouses: the impact of layout changes on heating and cooling energy load and occupants’ thermal comfort. Architectural Science Review. 69(1). 72–87.

Zhang, Yuhan, et al.. (2024). Outdoor thermal performance of urban development patterns in Greater Adelaide since the late 19th century. Scientific Reports. 14(1). 29207–29207. 2 indexed citations

Kroll, David J., et al.. (2023). Wellbeing fostered by design: a framework for evaluating indoor environment performance. SHILAP Revista de lepidopterología. 4(1). 3 indexed citations

Sy‐Cordero, Arlene A., Mario Figueroa, Huzefa A. Raja, et al.. (2015). Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum. Tetrahedron. 71(47). 8899–8904. 15 indexed citations

Ayers, Sloan, Tyler N. Graf, Audrey F. Adcock, et al.. (2011). Obionin B: an o-pyranonaphthoquinone decaketide from an unidentified fungus (MSX 63619) from the order Pleosporales. Tetrahedron Letters. 52(40). 5128–5130. 15 indexed citations

Ayers, Sloan, Tyler N. Graf, Audrey F. Adcock, et al.. (2011). Cytotoxic xanthone–anthraquinone heterodimers from an unidentified fungus of the order Hypocreales (MSX 17022). The Journal of Antibiotics. 65(1). 3–8. 33 indexed citations

Alali, Feras Q., Ahmad A. Gharaibeh, Khaled Tawaha, et al.. (2010). Colchicinoids fromColchicum crocifoliumBoiss. (Colchicaceae). Natural Product Research. 24(2). 152–159. 9 indexed citations

Brantley, Scott J., Nicholas H. Oberlies, David J. Kroll, & Mary F. Paine. (2009). Two Flavonolignans from Milk Thistle (Silybum marianum) Inhibit CYP2C9-Mediated Warfarin Metabolism at Clinically Achievable Concentrations. Journal of Pharmacology and Experimental Therapeutics. 332(3). 1081–1087. 70 indexed citations

Deep, Gagan, Komal Raina, Rana P. Singh, et al.. (2008). Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin. International Journal of Cancer. 123(12). 2750–2758. 29 indexed citations

10.

Deep, Gagan, Nicholas H. Oberlies, David J. Kroll, & Rajesh Agarwal. (2008). Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway. Oncogene. 27(28). 3986–3998. 50 indexed citations

11.

Deep, Gagan, Nicholas H. Oberlies, David J. Kroll, & Rajesh Agarwal. (2007). Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis. 28(7). 1533–1542. 63 indexed citations

12.

Davis-Searles, Paula R., Yuka Nakanishi, Nam-Cheol Kim, et al.. (2005). Milk Thistle and Prostate Cancer: Differential Effects of Pure Flavonolignans from Silybum marianum on Antiproliferative End Points in Human Prostate Carcinoma Cells. Cancer Research. 65(10). 4448–4457. 194 indexed citations

13.

Peebles, Katherine A., et al.. (2001). Catalytic inhibition of human DNA topoisomerase IIα by hypericin, a naphthodianthrone from St. John’s wort (Hypericum perforatum)44Abbreviations: SJW, St. John’s wort; topo II, topoisomerase IIα; CAT, chloramphenicol acetyltransferase; and XRE, xenobiotic response element.. Biochemical Pharmacology. 62(8). 1059–1070. 27 indexed citations

14.

Anchordoquy, Thomas J., et al.. (1998). Stability of lipid/DNA complexes during agitation and freeze–thawing. Journal of Pharmaceutical Sciences. 87(9). 1046–1051. 47 indexed citations

15.

Meyer, Jeffrey D., Richard Falk, Robert M. Kelly, et al.. (1998). Preparation and in Vitro Characterization of Gentamycin-Impregnated Biodegradable Beads Suitable for Treatment of Osteomyelitis. Journal of Pharmaceutical Sciences. 87(9). 1149–1154. 44 indexed citations

16.

Kroll, David J.. (1997). Homologous and Heterologous Protein–Protein Interactions of Human DNA Topoisomerase IIα. Archives of Biochemistry and Biophysics. 345(2). 175–184. 14 indexed citations

17.

Anchordoquy, Thomas J., John F. Carpenter, & David J. Kroll. (1997). Maintenance of Transfection Rates and Physical Characterization of Lipid/DNA Complexes after Freeze-Drying and Rehydration. Archives of Biochemistry and Biophysics. 348(1). 199–206. 77 indexed citations

18.

Kroll, David J., et al.. (1995). Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.. Molecular Pharmacology. 47(4). 696–706. 17 indexed citations

19.

Kroll, David J., et al.. (1994). Escape from the antiproliferative effect of transforming growth factor-β1 in LLC-PK1 renal epithelial cells. Kidney International. 45(3). 642–649. 6 indexed citations

20.

Kroll, David J., M. Elizabeth Graichen, & Thomas B. Leonard. (1988). Strain difference in rat renal microsomal epoxide hydrolase elevation after mercuric chloride treatment. Carcinogenesis. 9(2). 193–198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact